Reduction strategies
Supply reduction refers to policing efforts to curb the manufacture and distribution of alcohol, tobacco, cannabis and other psychoactive substances. Demand reduction refers to preventive efforts to decrease demand for such substances. Harm reduction refers to policies and interventions aimed at reducing the harmful consequences of alcohol, tobacco, cannabis and other psychoactive substance use. A focus on harm reduction does not intend to send a message to the community that risky behaviours and the use of psychoactive substances or drugs are acceptable. Rather, such policies are formulated based on the scientific evidence regarding what works to improve public health and reduce social harms when tobacco, alcohol, cannabis and other psychoactive substances are already being used. [4] [5] [6] 
Harms of marijuana
Scientific research has established that cannabis is associated with a range of potential harms to individuals and to society. Data on smoking cannabis indicate that this practice is linked to cardiovascular and respiratory disorders, as well as to cognitive impairment and mental disorders. [7] Exposure to cannabis in adolescence, a time of significant neurodevelopment, is associated with a higher risk for psychotic disorders in later life. The risk is dose related. [8] Highly potent cannabis represents a significant public health problem. Acute cannabis use, for example, is associated with increased risk of motor vehicle collisions, including fatal crashes. [9] Cannabis use should therefore be prevented, and its continued use treated, using evidencebased approaches.
Benefits of marijuana
Medications such as dronabinol and nabilone consist of psychoactive ingredients of the cannabis plant, and are available in a number of countries for the treatment of medical conditions, such as nausea after chemotherapy, pain and spasticity. There is ongoing interest in the use of psychoactive ingredients of the cannabis plant in various other medical contexts, including for weight gain in HIV-positive patients. However, there are relatively few rigorous data in this area, and little is known about safe dose limits. [10] In the SA setting, there is a need for greater health research in general, including work on cannabis. This needs to be balanced against national health research priorities, which have highlighted the importance of additional research on several aspects of mental health that are relevant to SA's burden of disease, including mortality and morbidity. [11] 
Recommendations
• The National Drug Master Plan emphasises the importance of an integrated approach to supply reduction, demand reduction, and harm reduction strategies for combating alcohol, tobacco, cannabis and other psychoactive substance use and abuse in SA. For any particular substance, the balance between these three strategies, and the precise nature of the approach taken, should be evidence based.
• An assessment of currently available data in other countries indicates that alcohol is the substance that causes the most individual and societal harm, [12] and it is therefore key to put particular efforts into implementing the most evidence-based policies and interventions for combating such harm. This would encompass addressing a range of upstream drivers of alcohol use, as well as prevention and intervention efforts. [13] • Efforts at harm reduction have been particularly poorly resourced in SA, and given the enormous profits made by the liquor industry there is a need and obligation for this industry to be substantively more involved in evidence-based harm-reduction efforts.
• In terms of cannabis, local school survey data suggest high rates of experimentation during early adolescence; [14] hence, evidencebased interventions that include a strong focus on harm reduction are also needed in this population, which comprises a large proportion of South Africans.
• There are few data to indicate that supply reduction via criminalisation is effective in reducing cannabis abuse. At the same time there are insufficient data to indicate that the legalisation of cannabis will not be harmful. The immediate focus should therefore be decriminalisation rather than legalisation.
• With regard to medical marijuana, products based on ingredients of the cannabis plant should undergo standard evaluation by the Medicines Control Council to assess their benefits and risks for the treatment of particular medical conditions. • Evidence-based approaches that reduce harm from continued and chronic use of alcohol and cannabis (particularly among vulnerable groups such as adolescents and people with mental disorders) deserve greater attention and additional resources.
• Mental, neurological, and substance use disorders contribute significantly to SA's burden of disease. Proportionally and quantitatively, more research attention and resources need to focus on this area.
